resume

Test for "hidden cardiomyopathy" after sudden death

Test for “hidden cardiomyopathy” after sudden death

Genetic testing after a sudden unexplained death in a youngster whose autopsy results are inconclusive should be expanded to include genetic variants of cardiomyopathy, according to a new study. The researchers found that among 91 people who died suddenly and in whom the autopsy did not reveal a definitive cause, genetic variants associated with cardiomyopathy …

Test for “hidden cardiomyopathy” after sudden death Read More »

Sign up to resume Huntington's gene therapy trial |...

Sign up to resume Huntington’s gene therapy trial |…

A data safety monitoring board has recommended that enrollment of the highest dosage group be resumed in the European Phase 1/2 trial of AMT-130 in people with Huntington’s disease, but with additional security measures in place. UniQure, the developer of the investigational treatment, announced in August that enrollment in this high-dose group was voluntarily halted …

Sign up to resume Huntington’s gene therapy trial |… Read More »